Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
42,572,970
-
Share change
-
+494,029
-
Total reported value
-
$2,149,894,709
-
Put/Call ratio
-
164%
-
Price per share
-
$50.49
-
Number of holders
-
257
-
Value change
-
+$23,723,394
-
Number of buys
-
119
-
Number of sells
-
126
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2018
As of 30 Jun 2018,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
257 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,572,970 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Standard Life Aberdeen plc, NORTHERN TRUST CORP, RICE HALL JAMES & ASSOCIATES, LLC, and SNYDER CAPITAL MANAGEMENT L P.
This page lists
257
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.